Catalyst Wire Dossier Catalyst Wire Dossier

LEROCHOL

LERODALCIBEP-LIGA · LIB Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for LEROCHOL, covering 2025-12-12 to 2026-08-18. Get the full timeline:

Most recent: FDA Approved: LEROCHOL — Supplemental Application (LIB Therapeutics, Inc.)

See pricing